SEC Form 3 · accession 0001493152-26-041688
Tonix Pharmaceuticals Holding Corp. · TNXP
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Thomas Englese
Officer — Chief Commercial Officer
Period of report
Sep 4, 2026
Accepted (ET)
Sep 8, 2026 · 7:05 am EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001430306
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock, $0.001 par value per share | holding | — | — | — | 694 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock OptionF1 | $16.51 | holding | — | — | — | Sep 9, 2025 | Sep 9, 2034 | Common Stock | 500 | — | D |
| Stock OptionF2 | $8.05 | holding | — | — | — | Feb 25, 2026 | Feb 25, 2035 | Common Stock | 6,500 | — | D |
| Stock OptionF3 | $20.18 | holding | — | — | — | May 13, 2026 | May 13, 2035 | Common Stock | 12,480 | — | D |
| Stock OptionF4 | $14.29 | holding | — | — | — | Feb 24, 2027 | Feb 24, 2036 | Common Stock | 40,000 | — | D |
Explanation of responses
- F1The option was granted on September 9, 2024, pursuant to the Issuer's Amended and Restated 2020 Stock Incentive Plan, as amended. The option vests 1/3rd on the first anniversary of issuance and 1/36th each month thereafter for 24 months.
- F2The option was granted on February 25, 2025, pursuant to the Issuer's Amended and Restated 2020 Stock Incentive Plan, as amended. The option vests 1/3rd on the first anniversary of issuance and 1/36th each month thereafter for 24 months.
- F3The option was granted on May 13, 2025, pursuant to the Issuer's Amended and Restated 2020 Stock Incentive Plan, as amended. The option vests 1/4th on the first anniversary of issuance and 1/48th each month thereafter for 36 months.
- F4The option was granted on February 24, 2026, pursuant to the Issuer's Amended and Restated 2020 Stock Incentive Plan, as amended. The option vests 1/4th on the first anniversary of issuance and 1/48th each month thereafter for 36 months.